You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor infiltrating lymphocyte (TIL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Shanghai (BEN101)

Not yet recruiting
  • Solid Tumor
  • BEN101
  • Shanghai, Shanghai, China
  • +1 more
Apr 14, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Advanced Melanoma, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Melanoma
  • +3 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Epithelial Tumors, Malignant, Malignant Solid Tumor Trial in Barcelona (NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD)

Recruiting
  • Epithelial Tumors, Malignant
  • Malignant Solid Tumor
  • NEXTGEN-TIL
  • +2 more
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Nov 25, 2021

Advanced Liver Cancers, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Liver Cancers
  • +4 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

Not yet recruiting
  • Advanced Melanoma
  • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
  • Basel, Switzerland
    University Hospital Basel
May 19, 2023

Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Tumor-infiltrating Lymphocytes (TIL)
  • +5 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

PDO/PDO-TIL/PDOTS for Drug Screen

Recruiting
  • Liver Cancer
  • Metastatic Liver Cancer
  • Drug screen with PDO/PDO-TIL/PDOTS
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Jun 13, 2023

Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)

Terminated
  • Metastatic Melanoma
  • Tumor Infiltrating Lymphocytes
  • Nivolumab and Ipilimumab
  • New Haven, Connecticut
    Yale New Haven Hospital
Jul 20, 2022

Glioblastoma Multiforme, Adult Trial in Shijiazhuang (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Glioblastoma Multiforme, Adult
  • Tumor Infiltrating Lymphocytes (TIL)
  • Shijiazhuang, Hebei, China
    The Second Hospital of HeBei Medical University
Apr 11, 2022

Metastatic Melanoma Trial in Tampa (procedure, drug, other)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Surgery
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Metastatic Melanoma Trial in Santa Monica (Tumor Infiltrating Lymphocytes (TIL))

Terminated
Has Results
  • Metastatic Melanoma
  • Tumor Infiltrating Lymphocytes (TIL)
  • Santa Monica, California
    John Wayne Cancer Institute
Aug 27, 2021

Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

Active, not recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Glioblastoma Multiforme Trial in Shanghai (TIL, PD1-TIL)

Active, not recruiting
  • Glioblastoma Multiforme
  • Shanghai, Shanghai, China
    Huashan hospital, Fudan University
Aug 24, 2021

Advanced Melanoma Trial in Basel (Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2)

Recruiting
  • Advanced Melanoma
  • Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2
  • Basel, Switzerland
    Division of Medical Oncology and Cancer Immunology, University H
Aug 3, 2021

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,

Not yet recruiting
  • Lymphocytes
  • Tumor-Infiltrating
  • Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
  • Saint Petersburg, Florida
  • +1 more
Sep 15, 2023

Breast Cancer, Colorectal Cancer, Uveal Melanoma Trial in Orlando, Pittsburgh (TBio-4101, Pembrolizumab)

Recruiting
  • Breast Cancer
  • +2 more
  • Orlando, Florida
  • +1 more
Feb 1, 2023

Solid Tumor Trial (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumor
  • Tumor Infiltrating Lymphocytes
  • +3 more
  • (no location specified)
Dec 11, 2022

Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +4 more
  • GC101 TIL
  • Beijing, China
    Beijing Cancer Hospital
Nov 7, 2023

Solid Tumor Trial in Shanghai (GT201)

Recruiting
  • Solid Tumor
  • GT201
  • Shanghai, Shanghai, China
    Renji Hospital Affiliated to Shanghai Jiaotong University School
Feb 1, 2023

Solid Tumor Trial in China (GT201)

Recruiting
  • Solid Tumor
  • GT201
  • Zhengzhou, Henan, China
  • +4 more
Feb 6, 2023

Breast Cancer, Treatment Side Effects, Advanced Breast Cancer Trial in Shanghai (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Breast Cancer
  • +3 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Glioma Trial in Suzhou (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Glioma
  • Tumor Infiltrating Lymphocytes (TIL)
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Dec 19, 2022

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023